| Name | Title | Contact Details |
|---|
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Shields Nursing Center - El Cerrito is a El Cerrito, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Grace Assisted Living is a Nampa, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Beaumont Health is a not-for-profit organization formed by Beaumont Health System, Botsford Health Care and Oakwood Healthcare to provide high quality, efficient, accessible services in a caring environment for southeastern Michigan residents and beyond. It consists of eight hospitals with 3,337 beds, 153 outpatient sites, 5,000 physicians, more than 33,000 employees and about 3,500 volunteers. In 2013, the combined organizations had 168,047 inpatient admissions, 15,997 births and 492,677 emergency visits.